Clinical Practice Guidelines for Common Congenital Heart Diseases: A Scoping Review

Oscar Rivera-Torrejón1, Fabian A Chavez-Ecos2,3, Alvaro Taype-Rondan4,5

  • 1Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Peru.

PubMed

Insights

Clinical practice guidelines for congenital heart disease (CHD) often lack systematic reviews and fail to meet quality standards. This highlights a critical need for improved, evidence-based guidelines in CHD diagnosis and management.

Area of Science:

  • Cardiology
  • Evidence-based Medicine
  • Health Policy

Background:

  • Congenital heart diseases (CHD) require clear diagnostic and management protocols.
  • Clinical practice guidelines (CPG) aim to standardize care but their quality varies.
  • Assessing the reliability of current CPG for common CHDs is essential.

Purpose of the Study:

  • To evaluate the characteristics and reliability of CPG for diagnosing and managing common CHDs.
  • To identify gaps in the development and quality of existing CHD guidelines.

Main Methods:

  • A scoping review was conducted on CPG for specific CHDs (VSD, ASD, PDA, CoA) published/updated between 2018 and April 2023.
  • Searches included general search engines, CPG repositories, and guideline-issuing organizations.
  • The Appraisal of Guidelines Research and Evaluation II (AGREE-II) tool assessed guideline reliability, with ≥70% considered acceptable quality.

Main Results:

  • Twenty-one CPGs were identified for review.
  • Only 28.6% of the guidelines incorporated systematic reviews.
  • No CPG achieved an acceptable AGREE-II quality score, indicating significant deficiencies.

Conclusions:

  • Most CPG for CHD do not meet acceptable quality standards.
  • Key areas for improvement include systematic review implementation and stakeholder involvement.
  • There is a pressing need for developing robust, evidence-based guidelines to improve CHD diagnosis and management.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
38
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
61
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
169
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
41
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
36